Treatment of severe steroid refractory acute graft versus host disease with Infliximab, a chimeric human/mouse anti-TNF-alpha antibody

被引：0
|
作者：
Kobbe, G
Schneider, P
Fenk, R
Rohr, U
Neumann, F
Aivado, M
Rong, A
Hünerlitürkoglu, A
Haas, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [41] Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract
    Alex Ganetsky
    Noelle V. Frey
    Elizabeth O. Hexner
    Alison W. Loren
    Saar I. Gill
    Selina M. Luger
    James K. Mangan
    Mary Ellen Martin
    Daria V. Babushok
    William R. Drobyski
    Jacqueline Smith
    Colleen Timlin
    Craig W. Freyer
    Edward A. Stadtmauer
    David L. Porter
    Bone Marrow Transplantation, 2019, 54 : 212 - 217
  • [42] Low dose alemtuzumab is effective in the treatment of severe steroid-refractory acute graft-versus-host disease
    Repp, R
    Claviez, A
    Gahn, B
    Schub, N
    Beck, C
    Helm, F
    Gramatzki, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S97 - S97
  • [43] Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease:: a pilot study
    Greinix, HT
    Volc-Platzer, B
    Kalhs, P
    Fischer, G
    Rosenmayr, A
    Keil, F
    Hönigsmann, H
    Knobler, RM
    BLOOD, 2000, 96 (07) : 2426 - 2431
  • [44] Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease
    Jerkins, James H.
    Hamadani, Mehdi
    Zook, Felicia
    Epperla, Narendranath
    Shaw, Bronwen E.
    Saber, Wael
    Rizzo, J. Douglas
    Pasquini, Marcelo
    Chhabra, Saurabh
    Drobyski, William R.
    Hari, Parameswaran N.
    Shah, Nirav N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : E610 - E611
  • [45] Anti α4β7 Integrin Monoclonal Antibody (Vedolizumab) for the Treatment of Steroid-Resistant Severe Intestinal Acute Graft Versus Host Disease
    Danylesko, Ivetta
    Shouval, Roni
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Apel, Arie
    Shimoni, Avichai
    Nagler, Arnon
    BLOOD, 2017, 130
  • [46] Infliximab Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: A Case Report
    Piton, Gael
    Larosa, Fabrice
    Minello, Anne
    Becker, Marie-Claude
    Mantion, Georges
    Aubin, Francois
    Deconinck, Eric
    Hillon, Patrick
    Di Martino, Vincent
    LIVER TRANSPLANTATION, 2009, 15 (07) : 682 - 685
  • [47] Alpha 1 Anti-Trypsin (AAT): Novel Strategy to Treat Steroid Refractory Acute Graft Versus Host Disease
    Goldstein, Steven C.
    Koreth, John
    Magenau, John M.
    Soiffer, Robert J.
    Braun, Thomas
    Kennel, Maggi
    Goyetche, Reaha
    Pawarode, Attaphol
    Riwes, Mary M.
    Antin, Joseph H.
    Cutler, Corey S.
    Ho, Vincent T.
    Alyea, Edwin P., III
    Parkin, Brian L.
    Yanik, Gregory A.
    Choi, Sung Won
    Couriel, Daniel R.
    Levine, John E.
    Radojcic, Vedran
    Dinarello, Charles
    Reddy, Pavan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S57 - S57
  • [48] Infliximab for the treatment of steroid-refractory acute graft-versus-host disease (GVHD) in allogeneic stem cell transplant patients
    Rajpal, R
    Vandenberghe, E
    Browne, P
    Mccann, S
    King, F
    Conneally, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 113 - 113
  • [49] Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
    Drobyski, William R.
    Pasquini, Marcelo
    Kovatovic, Kathy
    Palmer, Jeanne
    Rizzo, J. Douglas
    Saad, Ayman
    Saber, Wael
    Hari, Parameswaran
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (12) : 1862 - 1868
  • [50] GLAT (Copaxone) for treatment of steroid-refractory acute graft versus host disease.
    Johnston, LJ
    Shizuru, JS
    Stockerl-Goldstein, KE
    Stuart, MJ
    Gasparetto, C
    Long, GD
    Rizzieri, DA
    Vredenburgh, JJ
    Blume, KG
    Negrin, RS
    Chao, NJ
    BLOOD, 2002, 100 (11) : 421A - 421A
12345